Geovax reports second quarter 2024 financial results and provides business update

Awarded barda project nextgen (png) contract to advance geovax's multi-antigen vaccine candidate, geo-cm04s1, into 10,000-participant randomized, comparative phase 2b covid-19 vaccine study

GOVX Ratings Summary

GOVX Quant Ranking